Skip to main content
SCLX
NASDAQ Life Sciences

Scilex Holding Co Divests $18.1M in Datavault AI Shares, a Significant Asset Sale

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$13.31
Mkt Cap
$112.849M
52W Low
$3.6
52W High
$34.27
52W Position info
270% above low
Off High info
61% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SCLX has more than doubled off its 52-week low of $3.6.

Summary

Scilex Holding Co, a 10% owner of Datavault AI Inc., reported the sale of $18.18 million worth of Datavault AI shares, representing a substantial divestment for the company.


Key Events · Ownership and Investor Activity · SCLX

  • Significant Asset Divestment

    Scilex Holding Co sold $18,176,455 worth of Datavault AI Inc. common stock through open market transactions.

  • Material Impact on Balance Sheet

    The total value of shares sold represents a substantial portion of Scilex Holding Co's market capitalization, indicating a significant change to its asset holdings.

  • Strategic Portfolio Adjustment

    The transactions occurred over three days, suggesting a deliberate reduction in its investment in Datavault AI Inc.


Analysis · SCLX · Life Sciences

This Form 4 filing indicates that Scilex Holding Co has sold a significant portion of its investment in Datavault AI Inc., totaling over $18.1 million across three transactions. This divestment represents a material change to Scilex Holding Co's asset base, equivalent to a substantial portion of its own market capitalization. While the specific reasons for the sale are not disclosed, such a large transaction could be driven by strategic re-evaluation of its investment portfolio, a need for capital for its own operations, or other financial considerations. Investors should monitor future disclosures for insights into the use of proceeds or the strategic rationale behind this significant asset disposition.

At the time of this filing, SCLX was trading at $13.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $112.8M. The 52-week trading range was $3.60 to $34.27. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SCLX - Latest Insights

SCLX
Jul 22, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.03
Real-time Price: $6.89 info
Change: -$0.140 (-2%) info
Market Cap: $59.694M info
SCLX
Jul 07, 2026, 9:26 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $6.89 info
Change: -$2.61 (-27%) info
Market Cap: $59.694M info
SCLX
Jul 06, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $9.08
Real-time Price: $6.89 info
Change: -$2.19 (-24%) info
Market Cap: $59.694M info
SCLX
Jun 29, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.80
Real-time Price: $6.89 info
Change: -$0.910 (-12%) info
Market Cap: $59.694M info
SCLX
Jun 24, 2026, 4:52 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.86
Real-time Price: $6.89 info
Change: +$0.030 (+0.44%) info
Market Cap: $59.694M info